Involvement of the C-terminal region of yeast proteinase B inhibitor 2 in its inhibitory action

Journal of Molecular Biology

Volumn 286, Issue 3, 1999, Pages 775-785

  Kojima, Shuichi ^a   Deguchi, Miki ^a   Miura, Kin ichiro ^a  

^a GAKUSHUIN UNIVERSITY   (Japan)

Author keywords

C terminal region; Mutagenesis; Protease inhibitor; Subtilisin; Yeast proteinase B inhibitor

Indexed keywords

ASPARAGINE; PROTEINASE INHIBITOR; SUBTILISIN; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEQUENCE HOMOLOGY; YEAST;

EID: 0033605078     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2498     Document Type: Article

References (52)

1. Barrett A. J., Salvesen G. S. Proteinase Inhibitors. 1986;Elsevier, Amsterdam.
2. Blow D. M. Structure and mechanisms of chymotrypsin. Acc. Chem. Res. 9:1976;145-152.
3. Bode W., Huber R. Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204:1992;433-451.
4. Bode W., Papamokos E., Musil D., Seemueller U., Fritz H. Refined 1.2 Å crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin. EMBO J. 5:1986;813-818.
5. Bryan P., Wang L., Hoskins J., Ruvinov S., Strausberg S., Alexander P., Amlog O., Gilliland G., Gallagher T. Catalysis of a protein folding reaction: mechanistic implications of the 2.0 Å structure of the subtilisin-prodomain complex. Biochemistry. 34:1995;10310-10318.
6. Bünning P., Holzer H. Natural occurrence and chemical modification of proteinase B inhibitors from yeast. J. Biol. Chem. 252:1977;5316-5323.
7. 1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem. Sci. 10:1985;20-24.
8. Carmona E., Dufour E., Plouffe C., Takebe S., Mason P., Mort J. S., Menard R. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry. 35:1996;8149-8157.
9. Chou P. Y., Fasman G. D. Prediction of the secondary structure of proteins from their amino acid sequence. Advan. Enzymol. 47:1978;45-148.
10. Coplen L. J., Frieden R. W., Goldberg D. P. A genetic screen to identify variants of bovine pancreatic trypsin inhibitor with altered folding energistics. Proteins: Struct. Funct. Genet. 7:1990;16-31.
11. 1-antitrypsin variants of therapeutic potential for emphysera and thrombosis. Nature. 313:1985;149-151.
12. Dohmae N., Takio K., Tsumuraya Y., Hashimoto Y. The complete amino acid sequences of two serine proteinase inhibitors from the fruiting bodies of a basidiomycetes,Pleurotus ostreatus. Arch. Biochem. Biophys. 316:1995;498-506.
13. Eder J., Rheinnecker M., Fersht A. R. Folding of subtilisin BPN′: role of the pro-sequence. J. Mol. Biol. 233:1993;293-304.
14. Fox T., de Miguel E., Mort J. S., Storer A. C. Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry. 31:1992;12571-12576.
15. Gallagher T., Gilliland G., Wang L., Bryan P. The prosegment-subtilisin BPN′ complex: crystal structure of a specific 'foldase'. Structure. 3:1995;907-914.
16. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
17. Hu Z., Haghjoo K., Jordan F. Further evidence for the structure of subtilisin propeptide and its interactions with mature subtilisin. J. Biol. Chem. 271:1996;3375-3384.
18. Jackson S. E., Fersht A. R. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity. Biochemistry. 33:1994;13880-13887.
19. Kojima S., Obata S., Kumagai I., Miura K. Alteration of the specificity of the Streptomyces subtilisin inhibitor by gene engineering. Bio/Technology. 8:1990;449-452.
20. Kojima S., Nishiyama Y., Kumagai I., Miura K. Inhibition of subtilisin BPN′ by reactive site P1 mutants of Streptomyces subtilisin inhibitor. J. Biochem. 109:1991;377-382.
21. Kojima S., Kumagai I., Miura K. Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action. J. Mol. Biol. 230:1993;395-399.
22. Kojima S., Fujimura K., Kumagai I., Miura K. Contribution of salt bridge in the protease inhibitor SSI (Streptomyces subtilisin inhibitor) to its inhibitory action. FEBS Letters. 337:1994;195-199.
23. Kojima S., Minagawa T., Miura K. The propeptide of subtilisin BPN′ as a temporary inhibitor and effect of an amino acid replacement on its inhibitory activity. FEBS Letters. 411:1997;128-132.
24. Kojima S., Minagawa T., Miura K. Tertiary structure formation in the propeptide of subtilisin BPN′ by successive amino acid replacements and its close relation to function. J. Mol. Biol. 277:1998;1007-1013.
25. Kominami E., Hoffschulte H., Leuschel L., Maier K., Holzer H. The substrate specificity of protease B from baker's yeast. Biochim. Biophys. Acta. 661:1981;136-141.
26. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl Acad. Sci. USA. 82:1985;488-492.
27. Laskowski M. Jr, Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 49:1980;593-626.
28. Laskowski M. Jr, Kato I., Ardelt W., Cook J., Denton A., Empie M. W., Kohr W. J., Park S. J., Parks K., Schatzley B. L., Schoenberger O. L., Tashiro M., Vichot G., Whatley H. F., Wieczorek A., Wieczorek M. Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues. Biochemistry. 26:1987;202-221.
29. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177:1984;531-556.
30. Longstaff C., Campbell A. F., Fersht A. R. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with α-chymotrypsin and wild-type and mutant subtilisin BPN′, and protein engineering to investigate inhibitory specificity and mechanism. Biochemistry. 29:1990;7339-7347.
31. Maier K., Müller H., Holzer H. Purification and molecular characterization of two inhibitors of yeast proteinase B. J. Biol. Chem. 254:1979a;8491-8497.
32. Maier K., Müller H., Tesch R., Trolp R., Witt I., Holzer H. Primary structure of yeast proteinase B inhibitor 2. J. Biol. Chem. 254:1979b;12555-12561.
33. Matsubara H., Kasper C. B., Brown D. M., Smith E. L. Subtilisin BPN′. I. Physical properties and amino acid composition. J. Biol. Chem. 240:1965;1125-1130.
34. McPhalen C. A., Svendsen I., Jonassen I., James M. N. G. Crystal and molecular structure of chymotrypsin inhibitor 2 from barley seeds in complex with subtilisin novo. Proc. Natl Acad. Sci. USA. 82:1985;7242-7246.
35. Mehle C. M., Tizard R., Lemmon S. K., Smart J., Jones E. W. Protease B of the lysosomelike vacuole of the yeast Saccharomyces cerevisiae is homologous to the subtilisin family of serine proteases. Mol. Cell. Biol. 7:1987;4390-4399.
36. Ohta Y., Hojo H., Aimoto S., Kobayashi T., Zhu X., Jordan F., Inouye M. Pro-peptide as an intramolecular chaperone: renaturation of denatured subtilisin E with a synthetic pro-peptide. Mol. Microbiol. 5:1991;1507-1510.
37. Potempa J., Korzus E., Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:1994;15957-15960.
38. Robertus J. D., Alden R. A., Birktoft J. J., Kraut J., Powers J. C., Wilcox P. E. X-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN′ Biochemistry. 11:1972;2439-2449.
39. Sakai M., Odani S., Ikenaka T. Importance of the carboxy-terminal four amino acid residues in the inhibitory activity of Streptomyces subtilisin inhibitor (with a revision of its carboxy-terminal sequence). J. Biochem. 87:1980;891-898.
40. Shinde U., Inouye M. Intramolecular chaperones and protein folding. Trends Biochem. Sci. 18:1993;442-447.
41. Shinde U., Inouye M. Folding mediated by an intramolecular chaperone: autoprocessing pathway of the precursor resolved via a substrate assisted catalysis mechanism. J. Mol. Biol. 247:1995a;390-395.
42. Shinde U., Inouye M. Folding pathway mediated by an intramolecular chaperone: characterization of the structural changes in pro-subtilisin E coincident with autoprocessing. J. Mol. Biol. 252:1995b;25-30.
43. Shinde U., Li Y., Chatterjee S., Inouye M. Folding pathway mediated by an intramolecular chaperone. Proc. Natl Acad. Sci. USA. 90:1993;6924-6928.
44. Sohl J. L., Shiau A. K., Rader S. D., Wilk B. J., Agard D. A. Inhibition of α-lytic protease by pro region C-terminal steric occlusion of the active site. Biochemistry. 36:1997;3894-3902.
45. Strausberg S., Alexander P., Wang L., Schwarz F., Bryan P. Catalysis of a protein folding reaction: thermodynamic and kinetic analysis of subtilisin BPN′ interactions with its propeptide fragment. Biochemistry. 32:1993;8112-8119.
46. Studier F. W., Rosenberg A. H., Dunn J. J., Dubendorff J. W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:1990;60-89.
47. Svendsen I., Jonassen I., Hejgaard J., Boisen S. Amino acid sequence homology between a serine protease inhibitor from barley and potato inhibitor I. Carlsberg Res. Commun. 45:1980;389-395.
48. Svendsen I., Boisen S., Hejgaard J. Amino acid sequence of serine protease inhibitor CI-1 from barley. Homology with barley inhibitor CI-2, potato inhibitor I, and leech eglin. Carlsberg Res. Commun. 47:1982;45-53.
49. Taguchi S., Kojima S., Terabe M., Kumazawa Y., Kohriyama H., Suzuki M., Miura K., Momose H. Molecular phylogenetic characterization of Streptomyces protease inhibitor family. J. Mol. Evol. 44:1997;542-551.
50. Tamura A., Kanaori K., Kojima S., Kumagai I., Miura K., Akasaka K. Mechanisms of the temporary inhibition in Streptomyces subtilisin inhibitor induced by an amino acid substitution, tryptophan 86 replaced by histidine. Biochemistry. 30:1991;5275-5286.
51. von Wilcken-Bergmann B., Tils D., Sartorius J., Auerswald E. A., Schroder W., Muller-Hill B. A. A synthetic operon containing 14 bovine pancreatic trypsin inhibitor genes is expressed inE. coli. EMBO J. 5:1986;3219-3225.
52. Winther J. R., Sorensen P. Propeptide of carboxypeptidase Y provides a chaperone-like function as well as inhibition of the enzymatic activity. Proc. Natl Acad. Sci. USA. 88:1991;9330-9334.